Zusammenfassung
In den letzten 20 Jahren ist eine deutliche Zunahme von Suchterkrankungen im höheren Lebensalter zu beobachten, die sich fortsetzen wird. Dabei unterscheidet man häufig zwischen einem frühen und einem späten Beginn („early onset“ [EO] vs. late onset [LO]). Early-onset-Suchtkranke sind aufgrund konstitutioneller und psychosozialer Vorbelastungen in einer ungünstigeren Ausgangsposition und werden durch die kumulierenden medizinischen, psychischen und sozialen Folgeerscheinungen im Verlauf der Suchterkrankung weiter geschädigt. Im höheren Alter sind sie gegenüber Gleichaltrigen mit LO-Suchtproblemen im Nachteil, durch mehr und schwerere chronische Krankheiten, psychische Komorbidität, geringere persönliche und soziale Ressourcen, eher dysfunktionale Problembewältigungsstrategien sowie soziale Probleme. Ihre Therapieadhärenz ist geringer und die Behandlung wegen der Kombination aus suchttypischen Verhaltensweisen, psychischer Komorbidität, somatischen Erkrankungen sowie in vielen Fällen vorliegenden kognitiven Beeinträchtigungen schwierig. Therapieziele müssen sehr individuell formuliert werden; Abstinenz als Maximalziel ist nur selten realistisch. Auch die Behandlung muss sehr individuell und oft unkonventionell durchgeführt werden. Dieser Beitrag gibt einen Überblick über die besonderen Merkmale von Verlauf, Symptomatik und Folgeproblemen bei EO-Suchtkranken, die das höhere Lebensalter erreicht haben. Dabei werden Alkohol, Medikamente, illegale Drogen und das Rauchen, aber auch Verhaltenssüchte berücksichtigt.
Abstract
During the past 20 years substance-related and addictive disorders in old age have markedly increased and this increase is going to continue. It is quite common to make a distinction between early onset (EO) and late onset (LO) of these disorders. EO-addicts are in a more disadvantageous position due to constitutional and psychosocial burdens and the cumulating harmful medical, mental and social consequences of addiction place them at a further disadvantage during the course of the disorder. In old age they are at a disadvantage compared to others of the same age with LO addiction problems because of more and more severe chronic medical conditions, psychiatric comorbidity, less personal and social resources, dysfunctional coping style, and social problems. They present with lower treatment adherence and the treatment is difficult due to the combination of typical addictive behavior, psychiatric comorbidity, somatic diseases and in many cases also cognitive impairment. Treatment goals must be mostly individually defined and abstinence is rarely a realistic goal. Even the treatment has to be carried out mostly individually and often unconventionally. This article gives a review of the characteristic features of the course, presentation and adverse consequences of addictive disorders in EO addicts who have reached old age. The article covers alcohol, prescription drugs, illicit drugs and smoking as well as behavioral addictions.
Literatur
Wolter DK (2011) Sucht im Alter – Altern und Sucht. Kohlhammer, Stuttgart
Maxwell JC (2015) Epidemiology and demography of nonmedical prescription drug use. In: Crome I, Wu LT, Rao R, Crome P (Hrsg) Substance use and older people. Wiley-Blackwell, Chichester, S 109–122
RCP (Royal College of Psychiatrists) (2018) Our invisible addicts. First report of the older persons’ substance misuse working group of the royal college of psychiatrists. College report CR211. https://www.rcpsych.ac.uk/files/pdfversion/CR211.pdf (Erstellt: 03.2018). Zugegriffen: 31. Mai 2018
Schepis TS, McCabe SE (2016) Trends in older adult nonmedical prescription drug use prevalence: results from the 2002–2003 and 2012–2013 national survey on drug use and health. Addict Behav 60:219–222
Dowling GJ, Weiss SR, Condon TP (2008) Drugs of abuse and the aging brain. Neuropsychopharmacology 33(2):209–218
Duncan DF, Nicholson T, White JB et al (2010) The baby boomer effect: changing patterns of substance abuse among adults ages 55 and older. J Aging Soc Policy 22(3):237–248
Han BH, Sherman S, Mauro PM et al (2017) Demographic trends among older cannabis users in the United States, 2006–13. Addiction 112:516–525
Subramaniam M, Wang P, Soh P et al (2015) Prevalence and determinants of gambling disorder among older adults: a systematic review. Addict Behav 41:199–209
Aartsen M (2015) Ageing and the development of alcohol use and misuse. In: Crome I, Wu LT, Rao R, Crome P (Hrsg) Substance use and older people. Wiley-Blackwell, Chichester, S 123–132
Grant BF, Chou SP, Saha TD et al (2017) Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001–2002 to 2012–2013. JAMA Psychiatry 74(9):911–923
Weyerer S (2017) Epidemiologie des Alkoholkonsums und alkoholbezogener Störungen im höheren Alter. Sucht 63(2):69–80
Chapman SLC, Wu LT (2015) Epidemiology and demography of illicit drug use and drug use disorders among adults aged 50 and older. In: Crome I, Wu LT, Rao R, Crome P (Hrsg) Substance use and older people. Wiley-Blackwell, Chichester, S 91–108
Liberto JG, Oslin DW (1995) Early versus late onset of alcoholism in the elderly. Int J Addict 30(13/14):1799–1818
Lieb B, Rosien M, Bonnet U, Scherbaum N (2008) Alkoholbezogene Störungen im Alter – Aktueller Stand zu Diagnostik und Therapie. Fortschr Neurol Psychiatr 76(2):75–85
Storr CL, Green KM (2015) Progression from substance use to the development of substance use disorders. In: Crome I, Wu LT, Rao R, Crome P (Hrsg) Substance use and older people. Wiley-Blackwell, Chichester, S 133–148
Wolter DK (2015) Alkohol im Alter. Trinkgewohnheiten, risikoarmer Konsum und alkoholbezogene Störungen. Z Gerontol Geriatr 48(6):557–570
Slade T, Chapman C, Swift W et al (2016) Birth cohort trends in the global epidemiology of alcohol use and alcohol-related harms in men and women: systematic review and metaregression. BMJ Open 6:e11827
Stumpf W (2003) Wenn Junkies in die Jahre kommen. In: Seeberger B, Braun A (Hrsg) Wie die anderen altern. Zur Lebenssituation alter Menschen am Rande der Gesellschaft. Mabuse-Verlag, Frankfurt a.M., S 143–147
Carew AM, Comiskey C (2018) Treatment for opioid use and outcomes in older adults: a systematic literature review. Drug Alcohol Depend 182:48–57
Grant BF, Saha TD, Ruan WJ et al (2016) Epidemiology of DSM-5 drug use disorder: results from the national epidemiologic survey on alcohol and related conditions-III. JAMA Psychiatry 73(1):39–47
Wolter DK (2017) Schmerzen und Schmerzmittelabhängigkeit im Alter. Die gerontopsychiatrische Perspektive. Kohlhammer, Stuttgart
Wu LT, Blazer DG (2014) Substance use disorders and psychiatric comorbidity in mid and later life: a review. Int J Epidemiol 43(2):304–317
Hser YI, Longshore D, Anglin MD (2007) The life course perspective on drug use: a conceptual framework for understanding drug use trajectories. Eval Rev 31(6):515–547
Ilomäki J, Paljärvi T, Korhonen MJ et al (2013) Prevalence of concomitant use of alcohol and sedative-hypnotic drugs in middle and older aged persons: a systematic review. Ann Pharmacother 47(2):257–268
Oslin DW (2004) Late-life alcoholism: issues relevant to the geriatric psychiatrist. Am J Geriatr Psychiatry 12(6):571–583
Kutschke A (2012) Sucht – Alter – Pflege. Praxishandbuch für die Pflege suchtkranker alter Menschen. Huber, Bern
Blow FC, Brockmann LM, Barry KL (2004) Role of alcohol in late-life suicide. Alcohol Clin Exp Res 28(5 Suppl):48S–56S
Vogt I (2013) Süchtige alte Frauen. Spezifische Problemlagen, typische Abhängigkeitsmuster. Psychother Alter 10(1):73–82
Schutte KK, Brennan PL, Moos RH (2009) Treated and untreated remission from problem drinking in late life: post-remission functioning and health-related quality of life. Drug Alcohol Depend 99(1–3):150–159
Rehm J, Imtiaz S (2016) A narrative review of alcohol consumption as a risk factor for global burden of disease. Subst Abuse Treat Prev Policy 11(1):37
Darville A, Hahn EJ (2014) Hardcore smokers: what do we know? Addict Behav 39(12):1706–1712
Forman-Hoffman VL, Hedden SL, Glasheen C et al (2016) The role of mental illness on cigarette dependence and successful quitting in a nationally representative, household-based sample of U.S. adults. Ann Epidemiol 26(7):447–454
Kerr S, Watson H, Tolson D et al (2006) Smoking after the age of 65 years: a qualitative exploration of older current and former smokers’ views on smoking, stopping smoking, and smoking cessation resources and services. Health Soc Care Community 14(6):572–582
Lester PE, Kohen I (2008) Smoking in the nursing home: a case report and literature review. J Am Med Dir Assoc 9(3):201–203
Gellert C, Schöttker B, Brenner H (2012) Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med 172(11):837–844
Mühlig S, Andreas S, Rüther T, Petersen KU (2015) Gender- und Altersaspekte (z. B. Frauen, Schwangerschaft, Jugendliche). S3-Leitlinie “Screening, Diagnostik und Behandlung des schädlichen und abhängigen Tabakkonsums”. http://www.awmf.org/leitlinien/detail/ll/076-006.html. Zugegriffen: 31. Mai 2018 (AWMF-Register Nr. 076-006. S 147–189)
Pilowsky DJ, Wu LT (2015) Tobacco use cessation. In: Crome I, Wu LT, Rao R, Crome P (Hrsg) Substance use and older people. Wiley-Blackwell, Chichester, S 212–222
Zbikowski SM, Magnusson B, Pockey JR et al (2012) A review of smoking cessation interventions for smokers aged 50 and older. Maturitas 71(2):131–141
Appel DW, Aldrich TK (2003) Smoking cessation in the elderly. Clin Geriatr Med 19(1):77–100
Hser YI, Evans E, Grella C et al (2015) Long-term course of opioid addiction. Harv Rev Psychiatry 23(2):76–89
Rosen D, Hunsaker A, Albert SM et al (2011) Characteristics and consequences of heroin use among older adults in the United States: a review of the literature, treatment implications, and recommendations for further research. Addict Behav 36(4):279–285
Vogt I (2009) Lebenslagen und Gesundheit älterer Drogenabhängiger. Ein Literaturbericht. Suchttherapie 10(1):17–24
Vogt I (Hrsg) (2011) Auch Drogenabhängige altern. Fachhochschul-Verlag, Frankfurt a.M.
Hamilton AB, Grella CE (2009) Gender differences among older heroin users. J Women Aging 21(2):111–124
Beynon CM, McVeigh J, Roe B (2007) Problematic drug use, ageing and older people: trends in the age of drug users in Northwest England. Ageing Soc 27:799–810
Rosen D, Smith ML, Reynolds CF 3rd (2008) The prevalence of mental and physical health disorders among older methadone patients. Am J Psychiatry 16(6):488–497
Beynon C, McVeigh J, Hurst A, Marr A (2010) Older and sicker: changing mortality of drug users in treatment in the north west of England. Int J Drug Policy 21(5):429–431
Bachi K, Sierra S, Volkow ND et al (2017) Is biological aging accelerated in drug addiction? Curr Opin Behav Sci 13:34–39
Reece AS (2007) Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers. Immun Ageing 24(4):6
Wolter DK (2017) Benzodiazepine absetzen im Alter – wann und wenn ja wie. Z Gerontol Geriatr 50(2):115–122
Crowe SF, Stranks EK (2017) The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis. Arch Clin Neuropsychol. https://doi.org/10.1093/arclin/acx120
Wolter DK (2017) Suchtpotenzial und andere Risiken von Benzodiazepinen und Z‑Drugs im Alter. Sucht 63(2):81–97
Volkow ND, Morales M (2015) The brain on drugs: from reward to addiction. Cell 162(4):712–725
Gressler LE, Martin BC, Hudson TJ, Painter JT (2018) Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans. Pain 159(3):451–459
Wolter DK (2017) Abhängigkeitspotenzial und andere Risiken von Opioidanalgetika im Alter. Sucht 63(2):99–114
Pilver CE, Libby DJ, Hoff RA, Potenza MN (2013) Problem gambling severity and the incidence of Axis I psychopathology among older adults in the general population. J Psychiatr Res 47(4):534–541
Tse S, Hong SI, Wang CW, Cunningham-Williams RM (2012) Gambling behavior and problems among older adults: a systematic review of empirical studies. J Gerontol B Psychol Sci Soc Sci 67(5):639–652
Schwager JC (2015) Pathologisches Glücksspiel im Alter. Psychother Alter 12(4):477–487
Mann K, Lemenager T, Zois E et al (2017) Comorbidity, family history and personality traits in pathological gamblers compared with healthy controls. Eur Psychiatry 42:120–128
Pietrzak RH, Morasco BJ, Blanco C et al (2007) Gambling level and psychiatric and medical disorders in older adults: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Geriatr Psychiatry 15(4):301–313
Pilver CE, Potenza MN (2013) Increased incidence of cardiovascular conditions among older adults with pathological gambling features in a prospective study. J Addict Med 7(6):387–393
Grant JE, Kim SW, Odlaug BL et al (2009) Late-onset pathological gambling: clinical correlates and gender differences. J Psychiatr Res 43(4):380–387
Brust JCM (2014) Neurologic complications of illicit drug abuse. Continuum (Minneap Minn) 20(3):642–656
Cadet JL, Bisagno V, Milroy CM (2014) Neuropathology of substance use disorders. Acta Neuropathol 127(1):91–107
Galvin R, Bråthen G, Ivashynka A, EFNS et al (2010) EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol 17(12):1408–1418
Sechi G, Serra A (2007) Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 6(5):442–455
Oscar-Berman M (2012) Function and dysfunction of prefrontal brain circuitry in alcoholic Korsakoff’s syndrome. Neuropsychol Rev 22(2):154–169
Cheng C, Huang CL, Tsai CJ et al (2017) Alcohol-related dementia: a systemic review of epidemiological studies. Psychosomatics 58:331–342
Schwarzinger M, Pollock BG, Hasan OSM, QalyDays Study Group (2018) Contribution of alcohol use disorders to the burden of dementia in France 2008–13: a nationwide retrospective cohort study. Lancet Public Health 3(3):e124–e132
Oudman E, Zwart E (2012) Quality of life of patients with Korsakoff’s syndrome and patients with dementia: a cross-sectional study. J Am Med Dir Assoc 13(9):778–781
Gerridzen IJ, Hertogh CMPM, Depla MF et al (2018) Neuropsychiatric symptoms in people with Korsakoff syndrome and other alcohol-related cognitive disorders living in specialized long-term care facilities: prevalence, severity, and associated caregiver distress. J Am Med Dir Assoc 19(3):240–247
Picton JD, Marino AB, Nealy KL (2018) Benzodiazepine use and cognitive decline in the elderly. Am J Health Syst Pharm 75(1):e6–e12
Salzman C, Shader RI (2015) Benzodiazepine use and risk for Alzheimer disease. J Clin Psychopharmacol 35(1):1–3
Cedernaes J, Osorio RS, Varga AW et al (2017) Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer’s disease. Sleep Med Rev 31:102–111
Zhong G, Wang Y, Zhang Y et al (2015) Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS ONE 10(3):e118333
Geyer D, Wolter DK, Scherbaum N et al (2014) Ältere Menschen. In: S3-Leitlinie “Screening, Diagnose und Behandlung alkoholbezogener Störungen”. http://www.awmf.org/uploads/tx_szleitlinien/076-001l_S3-Leitlinie_Alkohol_2016-02.pdf. Zugegriffen: 4. Juni 2018 (AWMF-Register Nr. 076-001. S. 272–287)
Moggi F (2014) Behandlung von Suchtpatienten mit komorbiden psychischen Störungen. Suchtmagazin (Bern) 1:15–19
Andrews T, Reddy L, Whelan P (2011) Addressing the needs of older people with co-morbid alcohol and mental health disorders: a case series from a London Community Mental Health Team (CMHT). Adv Dual Diagn 4(1):8–16
Rakshi M, Wilson I, Burrow S, Holland M (2011) How can older people’s mental health services in the UK respond to the escalating prevalence of alcohol misuse among older adults? Adv Dual Diagn 4(1):17–27
Chung TE, Gozdzik A, Palma Lazgare LI et al (2017) Housing first for older homeless adults with mental illness: a subgroup analysis of the at home/chez soi randomized controlled trial. Int J Geriatr Psychiatry 33(1):85–95
Hurstak E, Johnson JK, Tieu L et al (2017) Factors associated with cognitive impairment in a cohort of older homeless adults: results from the HOPE HOME study. Drug Alcohol Depend 178:562–570
Monds LA, Ridley NJ, Rivas C et al (2017) Cognition and adaptive functioning in older people attending drug and alcohol services. Int Psychogeriatr 29(5):815–823
Domínguez-Salas S, Díaz-Batanero C, Lozano-Rojas OM, Verdejo-García A (2016) Impact of general cognition and executive function deficits on addiction treatment outcomes: systematic review and discussion of neurocognitive pathways. Neurosci Biobehav Rev 71:772–801
Manning V, Verdejo-Garcia A, Lubman DI (2017) Neurocognitive impairment in addiction and opportunities for intervention. Curr Opin Behav Sci 13:40–45
Bolz M, Braasch S, Körner U, Der Paritätische Bayern et al (2017) Ältere Drogenabhängige in Versorgungssystemen. Ein Leitfaden. https://www.paritaet-bayern.de/netzwerk40plus/. Zugegriffen: 4. Juni 2018
Hoff T, Kuhn U, Kuhn S, Isfort M (Hrsg) (2017) Sucht im Alter – Maßnahmen und Konzepte für die Pflege. Springer, Berlin
Schomerus G, Matschinger H, Angermeyer MC (2014) Attitudes towards alcohol dependence and affected individuals: persistence of negative stereotypes and illness beliefs between 1990 and 2011. Eur Addict Res 20(6):293–299
van Boekel LC, Brouwers EP, van Weeghel J, Garretsen H (2013) Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend 131(1/2):23–35
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
D.K. Wolter gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren.
Caption Electronic Supplementary Material
391_2018_1440_MOESM1_ESM.docx
Online finden sich noch eine Übersicht zu den körperlichen Alkoholfolgekrankheiten sowie zusätzliche Literatur, Tabelle e1: Körperliche Alkoholfolgekrankheiten
Rights and permissions
About this article
Cite this article
Wolter, D.K. Altgewordene Suchtkranke. Z Gerontol Geriat 51, 758–769 (2018). https://doi.org/10.1007/s00391-018-1440-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00391-018-1440-6